Cathie Wood of ARK Invest added Rubrik and Prime Medicine to her portfolio on Sept. 10. Rubrik, valued at $15.2 billion, specializes in data security and cloud-based protection. Prime Medicine, valued at $697.7 million, focuses on gene-editing therapies. Both stocks have seen significant YTD gains, catching Wood’s attention.

Wood’s ARK Next Generation Internet ETF invested in Rubrik and Prime Medicine, reflecting her focus on disruptive innovation. Rubrik’s strong subscription revenue growth and Prime Medicine’s promising gene-editing technology make them compelling investments. Rubrik’s financials show improved margins and positive free cash flow, aligning with Wood’s investment thesis.

Read more at Yahoo Finance: Why Cathie Wood is Loading Up on These 2 Growth Stocks (And Should You?)